Back to SO Squarepoint Ops LLC

LCTXLCTX
14 quarters

Position history for SOSquarepoint Ops LLC's holdings in LINEAGE CELL THERAPEUTICS IN

Squarepoint Ops LLC holds 444,774 shares of LCTX (LINEAGE CELL THERAPEUTICS IN), worth $582,654 as of 2026-Q2. The position was increased (+210.6% shares). LCTX represents 0.0% of Squarepoint Ops LLC's portfolio.

Current Value

$582,654

Current Shares

444,774

Total Value Change

+$533,370

Total Shares Change

+411,918

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
444,774
+210.6%
$582,6540.0%$1.31
39
2026-Q1
Increased
143,190
+119.9%
$226,2400.0%$1.58
37
2025-Q4
New
65,109
-
$108,7320.0%$1.67
30
2025-Q3
Exited
0
-100.0%
$00.0%$1.69
0
2025-Q2
Increased
511,107
+42.9%
$463,7780.0%$0.91
32
2025-Q1
Increased
357,772
+288.9%
$161,5700.0%$0.45
36
2024-Q4
New
92,001
-
$46,2310.0%$0.50
31
2024-Q3
Exited
0
-100.0%
$00.0%$0.91
0
2024-Q2
Decreased
44,307
-76.9%
$44,1870.0%$1.00
0
2024-Q1
Increased
191,895
+10.7%
$284,0050.0%$1.48
26
2023-Q4
Increased
173,298
+603.6%
$188,8950.0%$1.09
37
2023-Q3
Decreased
24,631
-22.9%
$29,0650.0%$1.18
0
2023-Q2
Decreased
31,925
-2.8%
$45,0140.0%$1.41
0
2023-Q1
New
32,856
-
$49,2840.0%$1.50
28

Other major holders of LCTX: BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used